CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹3.76 Cr | ₹3.91 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr |
What is the latest Contingent Liabilities ratio of CONCORD BIOTECH ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹3.76 Cr |
| Mar2025 | ₹3.91 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹13 Cr |
How is Contingent Liabilities of CONCORD BIOTECH Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3.76 Cr | -3.73 | |
| Mar2025 | ₹3.91 Cr | -72.67 | |
| Mar2024 | ₹14 Cr | 0.00 | |
| Mar2023 | ₹14 Cr | 7.43 | |
| Mar2022 | ₹13 Cr | - | |
Compare Contingent Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹14,856.3 Cr | 13% | 10.6% | -30.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 13% |
10.6% |
-30.9% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses